Bio-Labs expands international operations into CIS countries by commencing regulatory registrations in several therapeutic categories.
Bio-labs expands international operations
![Bio-labs expands international operations](https://bio-labs.net/wp-content/uploads/2016/03/russia-mapresize-260x121.jpg)
Bio-Labs expands international operations into CIS countries by commencing regulatory registrations in several therapeutic categories.
A new range of dermatology products under the brand name of BUSID CREAM are launched including Fusidic Acid, Betamethasone & Hydrocortisone for better skin infections treatment.
Bio-Labs launches BIO-D3, a new range of Vitamin D3 products including dosage forms in liquid ampoules, tablets and drops.
Kenya Pharmacy & Poison Board (PPB) grants Good Manufacturing Practices license to Bio-Labs after successful plant inspection allowing further market expansion in the African continent.